Pain play Spinifex secures $45 million series C

Spinifex Pharmaceuticals Pty. Ltd. (South Yarra, Australia) raised an undisclosed amount in a tranched $45 million series C round led by new investor Novo A/S. New investor Canaan Partners also participated along with existing investors GBS Venture Partners; Brandon Capital Partners; Uniseed; and UniQuest. Novo A/S's Steve Collins and Heath Lukatch will join Spinifex's board along with Canaan's Brent Ahrens. ...